等待開盤 07-06 09:30:00 美东时间
-0.009
-0.02%
Advanced Enzyme Technologies Ltd ( ($IN:ADVENZYMES) ) has issued an announcemen...
07-04 17:52
BRIEF-Alarum Technologies Provides Update Regarding Recent Law Enforcement Action July 3 (Reuters) - Alarum Technologies Ltd ALAR.TA : ALARUM TECHNOLOGIES PROVIDES UPDATE REGARDING RECENT LAW ENFORCEMENT ACTION ALARUM TECHNOLOGIES LTD: CURRENTLY EXPERIENCING DISRUPTIONS TO A PORTION OF ITS SERVICES
07-03 20:29
BRIEF-NHTSA - Closes Preliminary Evaluation On 441,002 American Honda Motor US Vehicles Due To Inadvertent Deployment Of Side Air Bags June 27 (Reuters) - NHTSA - CLOSES PRELIMINARY EVALUATION (PE) ON 441,002 AMERICAN HONDA MOTOR CO US VEHICLES DUE TO INADVERTENT DEPLOYMENT OF SIDE AIR BAGS Source t
06-27 15:12
BRIEF-Warner Bros Discovery Says HBO Max To Launch Moments, New Advertising Format, Across Some International Territories By 2026 End June 19 (Reuters) - Warner Bros Discovery Inc WBD.O : WARNER BROS DISCOVERY: HBO MAX TO LAUNCH MOMENTS, NEW ADVERTISING FORMAT, ACROSS SOME INTERNATIONAL TERRITORIES
06-19 20:41
BRIEF-Truecaller Says Ad Flag Removed June 16 (Reuters) - Truecaller AB TRUEb.ST : TRUECALLER PROVIDES AN UPDATE ON RECENT DEVELOPMENTS IN ITS ADVERTISING BUSINESS FLAG ON TRUECALLER'S AD INVENTORY BY LARGEST DEMAND PARTNER REMOVED OBSERVES MARGINAL REVENUE IMPROVEMENT FROM PARTNER AFTER FLAG REMOVA
06-16 15:17
Advanced Enzyme Technologies Ltd ( ($IN:ADVENZYMES) ) has shared an announcemen...
06-06 23:22
BRIEF-Climb Bio - Announces Initial Phase 1 Safety Data For CLYM116 - SEC Filing June 5 (Reuters) - Climb Bio Inc CLYM.O : CLIMB BIO - ANNOUNCES INITIAL PHASE 1 SAFETY DATA FOR CLYM116 - SEC FILING CLIMB BIO - NO SERIOUS ADVERSE EVENTS OR DOSE LIMITING TOXICITIES OBSERVED FOR CLYM116 IN PHASE 1 - SE
06-05 19:18
BRIEF-Remy CEO: There are no sacred cows in our portfolio June 4 (Reuters) - Remy Cointreau SA RCOP.PA CEO Franck Marilly tells analysts in a call: REMY CEO FRANCK MARILLY: WE WILL FOCUS ADVERTISING SPEND ON FEWER BRANDS AND REGIONS REMY CEO WE WILL TURN DISTRIBUTION DISRUPTION INTO A GROWTH OPPORTU
06-04 15:51
BRIEF-Legend Biotech Announces Promising Preliminary Clinical Data For LB2501 June 2 (Reuters) - Legend Biotech Corp LEGN.O : LEGEND BIOTECH: PROMISING INITIAL PHASE 1 CLINICAL DATA FOR LB2501 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA LEGEND BIOTECH: 100% ORR (6/6) OBSERVED IN
06-02 21:30
BRIEF-Mobvista Q1 2026 Group Revenue Up 32.2% To $581.3 Million May 31 (Reuters) - Mobvista Inc 1860.HK : MOBVISTA (1860.HK) DELIVERS SOLID 2026 Q1 PERFORMANCE FUELED BY AI-DRIVEN ADVERTISING MOBVISTA - Q1 2026 GROUP REVENUE UP 32.2% TO $581.3 MILLION MOBVISTA - Q1 2026 GROSS PROFIT UP 26.9% TO $121
06-01 09:04